FIELD: medicine.
SUBSTANCE: invention relates to medicine, particularly to obstetrics and gynecology. When treating a patient with uterine myoma uterine having fulfilled or not planning the reproductive function, uterine volume to 750 cm3, a diameter of the dominant myomatous nodule 6 to 10 cm, if at least one arterial vessel of diameter 0.2 cm and more is present in its structure, two-stage treatment is performed. First, X-ray endovascular selective embolisation of the arteries feeding the myomatous nodules is performed, and ultrasound ablation of myomatous nodules 30–45 days later.
EFFECT: method enables providing simultaneous minimally invasive treatment with higher effectiveness, consisting in stable regression of myomatous knot sizes and clinical myoma symptoms.
1 cl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CONSERVATIVE MYOMECTOMY IN PREGNANT WOMEN | 2015 |
|
RU2606494C1 |
| METHOD FOR DETERMINING NON-TARGET UTERINE ARTERY EMBOLIZATION | 2021 |
|
RU2768142C1 |
| METHOD FOR TRANSRADIAL ENDOVASCULAR EMBOLISATION OF UTERINE ARTERIES | 2014 |
|
RU2551947C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF TREATING UTERINE FIBROIDS USING FUS-MRI ABLATION IN THE PATIENTS OF REPRODUCTIVE AGE AT THE STAGE OF PREGNANCY PLANNING | 2019 |
|
RU2716337C1 |
| METHOD FOR PREDICTION OF RISK OF RECURRENCE OF SYMPTOMATIC UTERINE MYOMA AFTER SELECTIVE EMBOLIZATION OF UTERINE ARTERIES | 2021 |
|
RU2766809C1 |
| METHOD FOR SURGICAL TREATMENT OF METRA FIBROIDS IN WOMEN OF REPRODUCTIVE AGE | 2020 |
|
RU2750911C1 |
| METHOD FOR PREDICTION OF HYSTEROMYOMA REGRESSION | 2015 |
|
RU2596093C1 |
| METHOD FOR SURGICAL TREATING UTERINE MYOMA | 2002 |
|
RU2223700C1 |
| METHOD FOR TREATMENT OF UTERUS MYOMA | 2006 |
|
RU2289415C1 |
| METHOD FOR COMPLEX CONSERVATIVE TREATMENT OF UTERINE MYOMA | 2016 |
|
RU2632105C1 |
